Takeda Pharmaceutical Company Limited (TYO:4502)
Japan flag Japan · Delayed Price · Currency is JPY
4,234.00
-46.00 (-1.07%)
May 9, 2025, 3:30 PM JST

TYO:4502 Income Statement

Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2016 - 2020
Period Ending
Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2016 - 2020
Revenue
4,581,5514,263,7624,027,4783,569,0063,197,812
Upgrade
Revenue Growth (YoY)
7.45%5.87%12.85%11.61%-2.84%
Upgrade
Cost of Revenue
1,580,2171,431,5051,253,1631,127,3081,013,655
Upgrade
Gross Profit
3,001,3342,832,2572,774,3152,441,6982,184,157
Upgrade
Selling, General & Admin
1,104,7661,053,819997,234886,327875,514
Upgrade
Research & Development
730,227728,617633,325526,087455,765
Upgrade
Other Operating Expenses
180,52135,05938,98710,43323,602
Upgrade
Operating Expenses
2,658,7472,339,0202,154,6481,841,6361,760,110
Upgrade
Operating Income
342,587493,237619,667600,062424,047
Upgrade
Interest Expense
-210,065-115,392-116,973-122,432-130,806
Upgrade
Interest & Investment Income
46,54911,6285,7814,7632,153
Upgrade
Earnings From Equity Investments
-3,9866,473-8,630-15,36776
Upgrade
Currency Exchange Gain (Loss)
--13,612-9,729-3,903-15,575
Upgrade
Other Non Operating Income (Expenses)
-1-31,5203,975-26,1191,118
Upgrade
EBT Excluding Unusual Items
175,084350,814494,091437,004281,013
Upgrade
Merger & Restructuring Charges
--81,358-59,234-83,836-115,875
Upgrade
Gain (Loss) on Sale of Investments
--22,4168,482-
Upgrade
Gain (Loss) on Sale of Assets
-7,9758,9018,164235,117
Upgrade
Asset Writedown
--139,809-62,484-54,421-17,521
Upgrade
Legal Settlements
--45,212-16,455-20,319-17,401
Upgrade
Other Unusual Items
--39,619-12,1457,497902
Upgrade
Pretax Income
175,08452,791375,090302,571366,235
Upgrade
Income Tax Expense
66,941-91,40658,05272,405-9,936
Upgrade
Earnings From Continuing Operations
108,143144,197317,038230,166376,171
Upgrade
Minority Interest in Earnings
-215-130-21-107-166
Upgrade
Net Income
107,928144,067317,017230,059376,005
Upgrade
Net Income to Common
107,928144,067317,017230,059376,005
Upgrade
Net Income Growth
-25.09%-54.55%37.80%-38.81%749.90%
Upgrade
Shares Outstanding (Basic)
1,5791,5641,5521,5641,562
Upgrade
Shares Outstanding (Diluted)
1,6051,5801,5701,5771,574
Upgrade
Shares Change (YoY)
1.58%0.67%-0.46%0.23%0.47%
Upgrade
EPS (Basic)
68.3692.09204.29147.14240.72
Upgrade
EPS (Diluted)
67.2391.16201.94145.87238.96
Upgrade
EPS Growth
-26.25%-54.86%38.44%-38.96%745.88%
Upgrade
Free Cash Flow
856,387540,924836,499999,853899,725
Upgrade
Free Cash Flow Per Share
533.46342.28532.85633.95571.78
Upgrade
Dividend Per Share
-188.000180.000180.000180.000
Upgrade
Dividend Growth
-4.44%---
Upgrade
Gross Margin
65.51%66.43%68.88%68.41%68.30%
Upgrade
Operating Margin
7.48%11.57%15.39%16.81%13.26%
Upgrade
Profit Margin
2.36%3.38%7.87%6.45%11.76%
Upgrade
Free Cash Flow Margin
18.69%12.69%20.77%28.02%28.14%
Upgrade
EBITDA
1,103,9831,137,6981,210,6501,183,213983,718
Upgrade
EBITDA Margin
24.10%26.68%30.06%33.15%30.76%
Upgrade
D&A For EBITDA
761,396644,461590,983583,151559,671
Upgrade
EBIT
342,587493,237619,667600,062424,047
Upgrade
EBIT Margin
7.48%11.57%15.39%16.81%13.26%
Upgrade
Effective Tax Rate
38.23%-15.48%23.93%-
Upgrade
Updated Jan 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.